CCR5 and Alzheimer disease: Several studies using genetic tools modulating chemotaxis in different murine models of AD by down- or over-expressing some chemokines (CCR5, CCL5, CCL2, CCR2, CX3CR1) showed a direct impact on amyloid burden and memory decline [39–41].